Christopher J. Senner - Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher J. Senner since 7/7/2023

Holdings reported by Christopher J. Senner for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 27,000 Jun 5, 2024 Direct Common Stock

Transactions reported by Christopher J. Senner for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership